Inogen (INGN) Operating Margin Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -820.00 |
| Dec 31, 2025 | -392.00 |
| Sep 30, 2025 | -505.00 |
| Jun 30, 2025 | -306.00 |
| Mar 31, 2025 | -668.00 |
| Dec 31, 2024 | -748.00 |
| Sep 30, 2024 | -1,761.00 |
| Jun 30, 2024 | -1,998.00 |
| Mar 31, 2024 | -2,624.00 |
| Dec 31, 2023 | -4,370.00 |
| Sep 30, 2023 | -6,655.00 |
| Jun 30, 2023 | -2,849.00 |
| Mar 31, 2023 | -4,137.00 |
| Dec 31, 2022 | -7,453.00 |
| Sep 30, 2022 | -2,184.00 |
| Jun 30, 2022 | -1,603.00 |
| Mar 31, 2022 | -2,751.00 |
| Dec 31, 2021 | -2,087.00 |
| Sep 30, 2021 | -205.00 |
| Jun 30, 2021 | -177.00 |
| Mar 31, 2021 | -1,039.00 |
| Dec 31, 2020 | -1,605.00 |
| Sep 30, 2020 | -1,176.00 |
| Jun 30, 2020 | -1,572.00 |
| Mar 31, 2020 | -1,008.00 |
| Dec 31, 2019 | -1,166.00 |
| Sep 30, 2019 | -330.00 |
| Jun 30, 2019 | -102.00 |
| Mar 31, 2019 | -117.00 |
| Dec 31, 2018 | 272.00 |
| Sep 30, 2018 | 643.00 |
| Jun 30, 2018 | 255.00 |
| Mar 31, 2018 | 699.00 |